Screener
Veradermics MANE Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The source filing: Veradermics’s 10-K, filed March 30, 2026.
- Filed
- Mar 30, 2026, 5:35 PM EDT
- Fiscal year
- FY2025
- Accession
- 0001827635-26-000013
| (in thousands, except share and per share amounts) | As of December 31, 2025 | As of December 31, 2024 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $2,126 | $2,248 |
| Accrued expenses | 6,979 | 2,470 |
| Other current liabilities and lease liabilities | 47 | — |
| Total current liabilities | 9,152 | 4,718 |
| Lease liabilities - non-current | 4 | — |
| Total liabilities | 9,156 | 4,718 |
| Commitments and contingencies (Note 10) |
Item 16. Form 10-K Summary
FAQ
- What is Veradermics's accrued expenses?
- Veradermics (MANE) reported accrued expenses of $47K in Q4 2025.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Veradermics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude